Personnel Information

写真a

SATO Hiroyuki


Job title

Assistant Professor

Graduate School 【 display / non-display

  • Tokyo University of Science, Graduate School, Division of Engineering, Doctor's Course, Completed

Campus Career 【 display / non-display

  • 2020.04
    -
    Now
    Tokyo Medical and Dental University, Medical Hospital, Central Clinical Facilities, Clinical Research Center, Assistant Professor
  • 2020.11
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Division of Public Health, Department of Clinical Biostatistics, Assistant Professor

Research Areas 【 display / non-display

  • Statistical science

 

Published Papers & Misc 【 display / non-display

  • Kato M, Hirakawa A, Sato H, Hanazawa R, Naito Y, Tochigi K, Sano T, Ishida S, Funahashi Y, Fujita T, Matsukawa Y, Hattori R, Tsuzuki T. Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate. International journal of clinical oncology. 2021.01; ( PubMed, DOI )

  • Ikenouchi T, Inaba O, Takamiya T, Inamura Y, Sato A, Matsumura Y, Sato H, Hirakawa A, Takahashi Y, Goya M, Sasano T, Nitta J. The impact of left atrium size on selection of the pulmonary vein isolation method for atrial fibrillation: Cryoballoon or radiofrequency catheter ablation. American heart journal. 2021.01; 231 82-92. ( PubMed, DOI )

  • Hirakawa A, Asano J, Sato H, Teramukai S. Master protocol trials in oncology: Review and new trial designs. Contemporary Clinical Trial Communication. 2018.12; 12 1-8. ( PubMed, DOI )

  • Hirakawa A, Sato H, Gosho M. Effect of design specifications in dose-finding trials for combination therapies in oncology. Pharmaceutical Statistics. 2016.11; 15 (6): 531-540. ( PubMed, DOI )

  • Sato H, Hirakawa A (co-first author), Hamada C. An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trials. Statistics in Medicine. 2016.10; 35 (23): 4093-4109. ( PubMed, DOI )

display all >>

Books etc 【 display / non-display

  • Hirakawa A, Sato H, Daimon T, Matsui S. Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted. Springer, 2018 (ISBN : 978-4-431-55573-5)

  • Sato H, Yamaguchi T, Ando Y, Nonaka T. Oncology Clinical Trials Successful Design, Conduct, and Analysis, Second Edition. Demos Medical Pub, 2018 The Evolution of the Drug Evaluation Process in Japan (ISBN : 978-0-8261-6872-6)

  • Hirakawa A, Sato H. Frontiers of Biostatistical Methods and Applications in Clinical Oncology. Springer, 2017 A comparative study of model-based dose-finding methods for two-agent combination trials (ISBN : 978-981-10-0126-0)

Conference Activities & Talks 【 display / non-display

  • Sato H, Asano J, Ando Y. Consideration of the estimation method for regional treatment effects in multi-regional clinical trials―regulatory perspectives-. International Symposium on Biopharmaceutical Statistics 2019.08

  • Sato H, Hirakawa A, Hamada C. An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trials. East Asia Regional Biometric Conference 2015 2015.12

  • Sato H. Statistical issues in evaluating MRCT – Experiences in Japan. ISBS/DIA Joint Statistical Conference 2015 2015.06

  • Sato H. Regulatory Japanese experience on adaptive clinical trial designs. Austria-Japan Joint Statistics Workshop 2015.03

  • Sato H, Hirakawa A, Hamada C. Dose-finding approach based on efficacy and toxicity outcomes in phase I oncology trials for Molecularly Targeted Agents. Eastern North American Region 2015 Spring meeting 2015.03